02.09.2012 • News

Bayer CEO Says Greek Euro Exit May Help

Leaving the euro zone could help Greece to recover economically and prevent the region's debt crisis from spreading, the head of German drugmaker Bayer was quoted as saying in a newspaper interview on Saturday.

The comments from Bayer CEO Marijn Dekkers add to a growing chorus of influential Germans speculating about the possible exit of Greece from the euro zone, despite Chancellor Angela Merkel's request for compatriots to tone down their rhetoric.

"Greece's exit from the euro may be better for all parties involved," Dekkers said, according to the Rheinische Post.

With its own currency, Greece might stand a better chance of escaping its economic slump, while keeping the euro strong would prevent a domino effect that could hit Spain and Portugal, Dekkers was quoted as saying.

He also said that if the drugs Bayer is developing are as successful as planned the company might become a top ten pharma company worldwide.

As a result, the company had no need to make a large takeover or merge with a competitor, he said.

Dekkers would neither sell nor seek to merge the Bayer MaterialScience unit with Lanxess or Evonik, he was quoted as saying.

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read